Aliases & Classifications for Cystitis

MalaCards integrated aliases for Cystitis:

Name: Cystitis 12 51 41 14 69 59
Infective Cystitis 69

Classifications:



External Ids:

Disease Ontology 12 DOID:1679
ICD10 32 N30 N30.9
ICD9CM 34 595 595.9
MeSH 41 D003556
NCIt 46 C26738

Summaries for Cystitis

PubMed Health : 59
About cystitis: Many women know the symptoms of cystitis (a urinary tract infection, or UTI) only too well: frequent trips to the bathroom and a stinging and burning sensation when passing urine. Although these symptoms are often very unpleasant, there are effective treatments. Uncomplicated cystitis usually clears up without any problems.Unfortunately, there is no sure-fire way to reliably prevent cystitis. And a lot of the common strategies women may use in day-to-day life have not yet been scientifically tested.This article is about acute cystitis – a bladder infection often also referred to as a urinary tract infection (UTI). It is not about chronic bladder problems such as interstitial cystitis. It also doesn't include information about treating cystitis in pregnant women.

MalaCards based summary : Cystitis, also known as infective cystitis, is related to acute cystitis and interstitial cystitis. An important gene associated with Cystitis is TRPV1 (Transient Receptor Potential Cation Channel Subfamily V Member 1), and among its related pathways/superpathways are PI3K-Akt signaling pathway and Influenza A. The drugs Hyaluronic acid and Acetylcholine have been mentioned in the context of this disorder. Affiliated tissues include prostate, kidney and bone, and related phenotypes are behavior/neurological and cardiovascular system

Wikipedia : 72 A urinary tract infection (UTI) is an infection that affects part of the urinary tract. When it affects... more...

Related Diseases for Cystitis

Diseases in the Cystitis family:

Acute Cystitis Chronic Cystitis

Diseases related to Cystitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 340)
# Related Disease Score Top Affiliating Genes
1 acute cystitis 33.7 CRP CXCL8 IL6 UPK1A
2 interstitial cystitis 32.3 CXCL8 EGF HBEGF IL6 KNG1 NGF
3 paine syndrome 31.1 NGF TAC1 TRPV1 UPK3A
4 prostatitis 30.9 CXCL8 IL6 TNF
5 bladder disease 30.7 CRP HBEGF IL6 NGF P2RX3 TAC1
6 bacteriuria 30.6 CXCL8 IL6 TLR4
7 acute pyelonephritis 30.6 CRP CXCL8 IL6
8 pyelonephritis 30.1 CRP CXCL8 IL6 TLR4 TNF UMOD
9 urinary tract obstruction 30.1 EGF HBEGF PTGS2 UMOD
10 gastroenteritis 30.0 CRP CXCL8 IL6 TNF
11 cholangitis 29.9 CRP IL6 TNF
12 fasciitis 29.9 CXCL8 IL6 TNF
13 meningitis 29.9 CRP CXCL8 IL6 TNF
14 apnea, obstructive sleep 29.9 CRP IL6 TNF
15 vesicoureteral reflux 1 29.9 UMOD UPK1A UPK3A
16 bronchiolitis obliterans 29.9 CXCL8 IL6 TNF
17 colitis 29.8 CXCL8 IL6 TLR4 TNF
18 irritable bowel syndrome 29.8 TAC1 TNF TRPV1
19 chronic fatigue syndrome 29.8 CXCL8 IL6 TNF
20 somatoform disorder 29.7 NGF TAC1 TRPV1
21 ileitis 29.7 IL6 TLR4 TNF
22 pulmonary disease, chronic obstructive 29.7 CRP CXCL8 IL6 TNF
23 sleep apnea 29.7 CRP CXCL8 IL6 TNF
24 peritonitis 29.7 CRP CXCL8 IL6 TNF
25 wegener granulomatosis 29.7 CRP CXCL8 IL6 TNF
26 bladder cancer 29.6 CXCL8 EGF HBEGF PTGS2 TNF UPK3A
27 pneumonia 29.6 CRP CXCL8 IL6 TLR4 TNF
28 arthritis 29.5 CXCL8 IL6 PTGS2 TNF
29 bacterial vaginosis 29.5 CXCL8 IL6 TLR4 TNF
30 bronchiolitis 29.5 CXCL8 IL6 TLR4 TNF
31 rheumatic disease 29.4 CRP PTGS2 TNF
32 esophagitis 29.4 CXCL8 IL6 PTGS2 TRPV1
33 urinary system disease 29.4 CRP IL6 TNF TRPV1 UMOD
34 rheumatoid arthritis 29.1 CRP CXCL8 IL6 PTGS2 TLR4 TNF
35 asthma 29.0 CXCL8 IL6 KNG1 NGF TAC1 TNF
36 transitional cell carcinoma 29.0 PTGS2 UPK1A UPK3A
37 hemorrhagic cystitis 12.4
38 eosinophilic cystitis 12.3
39 cystitis cystica 12.3
40 radiation cystitis 12.2
41 chronic cystitis 12.2
42 chronic interstitial cystitis 12.2
43 acute gonococcal cystitis 12.2
44 glandular cystitis 12.1
45 diphtheritic cystitis 12.0
46 urinary schistosomiasis 11.5
47 urethral syndrome 11.4
48 pelvic lipomatosis 11.2
49 chronic pain 11.2
50 bladder tuberculosis 11.2

Comorbidity relations with Cystitis via Phenotypic Disease Network (PDN): (show all 32)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Alzheimer Disease
Bladder Cancer Bladder Neck Obstruction
Bronchitis Chronic Kidney Failure
Chronic Myocardial Ischemia Decubitus Ulcer
Deficiency Anemia Esophagitis
Familial Atrial Fibrillation Generalized Atherosclerosis
Heart Disease Hydronephrosis
Hypertension, Essential Hypothyroidism
Iron Deficiency Anemia Ischemic Heart Disease
Neurogenic Bladder Osteoporosis
Paralytic Ileus Parkinson Disease, Late-Onset
Prostatic Hypertrophy Protein-Energy Malnutrition
Pyelonephritis Radiation Cystitis
Schizophreniform Disorder Transient Cerebral Ischemia
Urethral Stricture Urethritis

Graphical network of the top 20 diseases related to Cystitis:



Diseases related to Cystitis

Symptoms & Phenotypes for Cystitis

MGI Mouse Phenotypes related to Cystitis:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10 TACR1 TLR4 HBEGF TNF IL6 TRPV1
2 cardiovascular system MP:0005385 9.9 TACR1 CRP TLR4 HBEGF TNF IL6
3 integument MP:0010771 9.77 TACR1 CKAP4 TLR4 EGF HBEGF TNF
4 renal/urinary system MP:0005367 9.23 TLR4 FZD8 IL6 TRPV1 UMOD UPK3A

Drugs & Therapeutics for Cystitis

PubMedHealth treatment related to Cystitis: 59

For many women, cystitis is a one-time unpleasant problem. In others, it may keep coming back. Antibiotics have been proven to effectively relieve acute cystitis, and they usually work quickly. There are also some home remedies that may help, like drinking plenty of fluids or applying heat. Herbal products are available too.

Drugs for Cystitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 307)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 2 9004-61-9 53477741 24759
2
Acetylcholine Approved Phase 4,Phase 2,Phase 1,Early Phase 1 51-84-3 187
3
Methenamine Approved, Vet_approved Phase 4 100-97-0 4101
4
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 5311068 56032 68602
5
Ketorolac Approved Phase 4 74103-06-3, 66635-83-4 3826
6
Ibuprofen Approved Phase 4 15687-27-1 3672
7
Oxytocin Approved, Vet_approved Phase 4 50-56-6 53477758 439302
8
Ciprofloxacin Approved, Investigational Phase 4,Phase 3 85721-33-1 2764
9
Nitrofurantoin Approved, Vet_approved Phase 4,Phase 2 67-20-9 5353830
10
Morphine Approved, Investigational Phase 4 57-27-2 5288826
11
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
12
Cycloserine Approved Phase 4 68-41-7 6234 401
13
Levofloxacin Approved, Investigational Phase 4,Phase 3 100986-85-4 149096
14
Ofloxacin Approved Phase 4,Phase 3 82419-36-1 4583
15
Amoxicillin Approved, Vet_approved Phase 4 26787-78-0 33613 2171
16
Metoprolol Approved, Investigational Phase 4 51384-51-1, 37350-58-6 4171
17
Cephalexin Approved, Investigational, Vet_approved Phase 4 15686-71-2 27447
18
Fosfomycin Approved Phase 4 23155-02-4 446987
19
Lornoxicam Approved, Investigational Phase 4 70374-39-9 5282204
20
Piroxicam Approved, Investigational Phase 4 36322-90-4 54676228 5280452
21
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
22
gamma-Aminobutyric acid Approved, Investigational Phase 4 56-12-2 119
23
Cefotaxime Approved Phase 4 63527-52-6 5742673 456256
24
Cefoxitin Approved Phase 4 35607-66-0 441199
25
Cilastatin Approved, Investigational Phase 4 82009-34-5 6435415 5280454
26
Imipenem Approved Phase 4 64221-86-9, 74431-23-5 104838
27
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
28
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
29
BCG vaccine Investigational Phase 4,Phase 2
30 Adjuvants, Immunologic Phase 4,Phase 3,Phase 2,Phase 1
31 Protective Agents Phase 4,Phase 3,Phase 2,Early Phase 1
32 Viscosupplements Phase 4,Phase 2
33 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Gentamicins Phase 4,Phase 2
36 Pharmaceutical Solutions Phase 4,Phase 2,Phase 1
37 Anticoagulants Phase 4,Phase 2,Phase 1
38 Pentosan Sulfuric Polyester Phase 4
39 abobotulinumtoxinA Phase 4,Phase 2,Phase 1,Early Phase 1
40 Botulinum Toxins Phase 4,Phase 2,Phase 1,Early Phase 1
41 Botulinum Toxins, Type A Phase 4,Phase 2,Phase 1,Early Phase 1
42 Cholinergic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
43 Neuromuscular Agents Phase 4,Phase 2,Phase 1,Early Phase 1
44 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
45 onabotulinumtoxinA Phase 4,Phase 2,Phase 1,Early Phase 1
46 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
47 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
48 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1
49 Renal Agents Phase 4,Phase 3,Phase 2,Phase 1
50 Antimetabolites Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 233)

# Name Status NCT ID Phase Drugs
1 Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract Unknown status NCT02366676 Phase 4 IALURIL
2 Gentamicin Bladder Instillation Trial Unknown status NCT01884467 Phase 4 Gentamicin;Placebo
3 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
4 Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome Unknown status NCT01895153 Phase 4
5 Botulinum A Toxin in the Treatment of Patients With Painful Bladder Syndrome Unknown status NCT01157507 Phase 4 Intravesical injection of Botulinum A Toxin;Placebo
6 Intravesicular Onabotulinumtoxin A in Interstitial Cystitis Completed NCT02297100 Phase 4 Onabotulinumtoxin A
7 Usefulness of Dexmedetomidine on Post-operative Pain Management in Patients With Interstitial Cystitis Completed NCT01195116 Phase 4 Dexmedetomidine;Normal Saline
8 Intranasal Ketorolac Tromethamine (Sprix) for Acute Pain of Interstitial Cystitis Flare of Pain Completed NCT02000401 Phase 4 Ketorolac Tromethamine
9 Ibuprofen Versus Mecillinam for Uncomplicated Cystitis Completed NCT01849926 Phase 4 Ibuprofen;Mecillinam
10 Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis Completed NCT00919802 Phase 4 Oxytocin
11 Botox as a Treatment for Interstitial Cystitis in Women Completed NCT00194610 Phase 4 Botox
12 A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department Completed NCT01749605 Phase 4 Nitrofurantoin monohydrate/macrocrystals 100 mg BID x 3 days;ciprofloxacin 250 mg BID x 3 days
13 Management of Urinary Tract Infections in Primary Care Facilities. Completed NCT01132131 Phase 4
14 Reduction of Bladder Injection Pain With Belladonna Opiate Suppository Completed NCT02600715 Phase 4 Onabotulinumtoxin A (BoNT);belladonna;Morphine;Placebo;Active B&O suppository of belladonna
15 Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain Completed NCT02385266 Phase 4 D-Cycloserine;Placebo (for D-cycloserine)
16 A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections Completed NCT00965848 Phase 4 Doripenem
17 Interstitial Cystitis: Examination of the Central Autonomic Network Recruiting NCT03008382 Phase 4 Metoprolol Tartrate Oral Tablet;Placebo Oral Tablet
18 Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome Recruiting NCT01312259 Phase 4
19 Chronic Pain Risk Associated With Menstrual Period Pain Recruiting NCT02214550 Phase 4 microgestin 1/20
20 Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women Active, not recruiting NCT01966653 Phase 4 nitrofurantoin;fosfomycin
21 Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? Active, not recruiting NCT03038321 Phase 4 sofenacin;Tavanic;Xefo
22 Clinical Assessment of Urinary Antiseptics Methenamine and Methylthioninium in Recurrent Cystitis Not yet recruiting NCT03379389 Phase 4 Methenamine + Methylthioninium;Methenamine + Methylthioninium + Acriflavine + Atropa belladona;Antibiotics
23 Management of Sub-Clinical Bacteriuria in Pregnancy Not yet recruiting NCT03275623 Phase 4 Antibiotic
24 Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis Terminated NCT00086684 Phase 4 Pentosan polysulfate sodium 100 mg;Placebo;Pentosan polysulfate sodium 100 mg
25 Efficacy of Gralise® for Chronic Pelvic Pain Terminated NCT01678911 Phase 4 Gralise
26 Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli Terminated NCT02474706 Phase 4 Cefoxitin;imipenem
27 The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study Terminated NCT00164099 Phase 4 Synbiotic 2000
28 Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III Terminated NCT00194597 Phase 4 Viagra (sildenafil citrate)
29 Chronic Bladder Pain Syndrome in Women: Can Doxycycline Help? A Prospective Study Terminated NCT01879930 Phase 4 doxycycline;placebo
30 Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis Withdrawn NCT00361998 Phase 4 NITROFURANTOIN MACROCRYSTALS
31 Acupuncture for the Treatment of Interstitial Cystitis (IC) Symptoms Unknown status NCT00094874 Phase 3
32 Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia Unknown status NCT01145976 Phase 3 Cy-ATG;Flu-ATG
33 Efficacy Study of Adalimumab to Treat Interstitial Cystitis Completed NCT01295814 Phase 3 Adalimumab
34 Omalizumab in Interstitial Cystitis/Bladder Pain Syndrome Completed NCT01294878 Phase 3 omalizumab
35 URACYST® For the Treatment of GAG Deficient Interstitial Cystitis Completed NCT00150488 Phase 2, Phase 3
36 Efficacy and Safety of Cefditoren Pivoxil Versus Ciprofloxacin in Acute Uncomplicated Cystitis Completed NCT00598403 Phase 3 cefditoren pivoxil;Ciprofloxacin
37 Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS) Completed NCT00124306 Phase 3 Amitriptyline
38 A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression Completed NCT02497287 Phase 3 Esketamine (Intranasal Spray);Duloxetine (Oral Antidepressant);Escitalopram (Oral Antidepressant);Sertraline (Oral Antidepressant);Venlafaxine Extended Release (XR) (Oral Antidepressant)
39 D Mannose in Recurrent Urinary Tract Infections Completed NCT01808755 Phase 3 trimethoprim/sulfamethoxazole
40 A Comparison of the Effectiveness and Safety of Levofloxacin to That of Ciprofloxacin in Treating Complicated Urinary Tract Infection and Acute Pyelonephritis. Completed NCT00210886 Phase 3 levofloxacin
41 A Pilot Study of the Effects of Mirabegron on Symptoms in Patients With Interstitial Cystitis Recruiting NCT02787083 Phase 3 Mirabegron;Placebo
42 Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial Recruiting NCT01659723 Phase 2, Phase 3 Hyperbaric Oxygen
43 Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome Recruiting NCT02858453 Phase 3 AQX-1125 100 mg;AQX-1125 200 mg;Placebo
44 Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Recruiting NCT02460588 Phase 3 Cyclophosphamide;Placebo;Corticosteroid (prednisolone)
45 Maximizing Outcome of Multiple Sclerosis Transplantation Recruiting NCT03342638 Phase 3 Cyclophosphamide;Mesna;rATG;Methylprednisolone;G-CSF
46 Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis Active, not recruiting NCT02497976 Phase 3 Placebo
47 A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . Terminated NCT00451867 Phase 3 Mycophenolate Mofetil;Mycofenolate Mofetil (MMF);Placebo
48 Efficacy of Antimicrobial Prophylaxis for Shock Wave Lithotripsy (SWL) on Reducing Urinary Tract Infection (UTI) Terminated NCT01873690 Phase 3 Ciprofloxacin;Placebo
49 Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries Terminated NCT00134628 Phase 3
50 Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia Terminated NCT00002961 Phase 3 cyclophosphamide;cyclosporine;etoposide;methotrexate;Busulfan;Mesna

Search NIH Clinical Center for Cystitis

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: cystitis

Genetic Tests for Cystitis

Anatomical Context for Cystitis

MalaCards organs/tissues related to Cystitis:

38
Prostate, Kidney, Bone, Bone Marrow, Spinal Cord, Brain, Testes

Publications for Cystitis

Articles related to Cystitis:

(show top 50) (show all 1350)
# Title Authors Year
1
Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). ( 29341502 )
2018
2
Serum Cytokine Profiling in Cats with Acute Idiopathic Cystitis. ( 29356123 )
2018
3
Severe BK polyomavirus-induced hemorrhagic cystitis in a kidney transplant recipient with the absence of renal allograft involvement. ( 29143415 )
2018
4
FDA Brudac 2018 Criteria for Interstitial Cystitis/Bladder Pain Syndrome Clinical Trials: Future Direction for IC/BPS Research. ( 29452126 )
2018
5
The Therapeutic Effect of Human Embryonic Stem Cell-Derived Multipotent Mesenchymal Stem Cells on Chemical-Induced Cystitis in Rats. ( 29385783 )
2018
6
Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinumtoxina injection in the treatment of interstitial cystitis refractory to conventional treatment-A prospective, randomized, clinical trial. ( 29331031 )
2018
7
Encrusted Cystitis with Suspected Ureteral Obstruction Following Cystoscopic-Guided Laser Ablation of Ectopic Ureters in a Dog. ( 29372865 )
2018
8
Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study. ( 29307733 )
2018
9
Cystitis Cystica Glandularis: Radiological Imitator of Urothelial Carcinoma. ( 29421770 )
2018
10
Novel contrast mixture achieves contrast resolution of human bladder wall suitable for T1 mapping: applications in interstitial cystitis and beyond. ( 29392488 )
2018
11
In this issue - January/February 2018: Global challenges for Australian veterinariansa88A^a88Financial stress in veterinary studentsa88A^a88Genetic diversity of A. pleuropneumoniae serovarsa88A^a88Sequencing of canid alphaherpesvirus 1 a88A^a88Rib pivot lateral thoracotomya88A^a88Medical management of pseudomembranous cystitis in catsa88A^a88Recumbency and inspired O<sub>2</sub>concentration in anaesthetised horsesa88A^a88Practitioner preferences for equine castration. ( 29377086 )
2018
12
Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder. ( 29372285 )
2018
13
Endometriosis increased the risk of bladder pain syndrome/interstitial cystitis: A population-based study. ( 29318645 )
2018
14
Chronic cystitis associated with Plesiochorus cymbiformis (Rudolphi, 1819) Looss, 1901 (Digenea: Gorgoderidae) in a Loggerhead turtle Caretta caretta (Linnaeus 1758) (Testudines, Cheloniidae) from Brazil. ( 29394134 )
2018
15
Animal Model of Interstitial Cystitis/Bladder Pain Syndrome. ( 29385782 )
2018
16
A genome-scale DNA methylation study in women with interstitial cystitis/bladder pain syndrome. ( 29363787 )
2018
17
Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients. ( 29315774 )
2018
18
Bladder pain syndrome/interstitial cystitis is associated with asthma: A case-control study. ( 29441652 )
2018
19
Intravesicular cidofovir for BK hemorrhagic cystitis in pediatric patients after hematopoietic stem cell transplant. ( 29388318 )
2018
20
The efficacy of botulinum toxin A and sacral neuromodulation in the management of interstitial cystitis (IC)/bladder pain syndrome (BPS), what do we know? ICI-RS 2017 think thank, Bristol. ( 29363792 )
2018
21
Successful medical management of pseudomembranous cystitis in three cats with lower urinary tract obstruction. ( 29226304 )
2018
22
Animal Modelling of Interstitial Cystitis/Bladder Pain Syndrome. ( 29385788 )
2018
23
Placenta-Derived Decidua Stromal Cells for Hemorrhagic Cystitis after Stem Cell Transplantation. ( 29408819 )
2018
24
Differences in Urodynamic Parameters According to the Presence of a Hunner Lesion in Women With Interstitial Cystitis/Bladder Pain Syndrome. ( 29385787 )
2018
25
Struvite urolithiasis with eosinophilic polypoid cystitis in a shih tzu dog. ( 29386681 )
2018
26
Therapeutic effect of urine-derived stem cells for protamine/lipopolysaccharide-induced interstitial cystitis in a rat model. ( 28482861 )
2017
27
Repeated intravesical injections of platelet-rich plasma are effective in the treatment of interstitial cystitis: a case control pilot study. ( 29265766 )
2017
28
Urodynamic characteristics of pelvic lipomatosis with glandular cystitis patients correlate with morphologic alterations of the urinary system and disease severity. ( 28763116 )
2017
29
Inhibition of microRNA-214 promotes epithelial-mesenchymal transition process and induces interstitial cystitis in postmenopausal women by upregulating Mfn2. ( 28729638 )
2017
30
Cystitis due to capillaria infection in a dog and its treatment. ( 28848250 )
2017
31
Expression of programmed death ligand-1 on bladder tissues is detected in a clinically and histologically well-defined interstitial cystitis cohort. ( 29277923 )
2017
32
Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer. ( 29169704 )
2017
33
Expression profile of urothelial transcription factors in bladder biopsies with interstitial cystitis. ( 28626955 )
2017
34
Efficacy of N-acetylcysteine, D-mannose and Morinda citrifolia to Treat Recurrent Cystitis in Breast Cancer Survivals. ( 28882961 )
2017
35
Treatment of ulcerative compared to non-ulcerative interstitial cystitis with hyperbaric oxygen: a pilot study. ( 29383031 )
2017
36
Nosocomial BK Polyomavirus Infection Causing Hemorrhagic Cystitis Among Patients With Hematological Malignancies After Hematopoietic Stem Cell Transplantation. ( 28295968 )
2017
37
Interstitial cystitis intravesical therapy. ( 28791236 )
2017
38
von Brunn's Nests and Follicular Cystitis Following Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder. ( 28808621 )
2017
39
The therapeutic approach to different forms of cystitis: impact on public health. ( 28862726 )
2017
40
Case: Eosinophilic cystitis presenting as a bladder mass in an 11-year-old girl. ( 29072568 )
2017
41
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis. ( 28744284 )
2017
42
Cystitis Cystica as a Large Solitary Bladder Cyst. ( 28466074 )
2017
43
Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning. ( 28199755 )
2017
44
Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study. ( 28056917 )
2017
45
Enhancement of S1P-induced contractile response in detrusor smooth muscle of rats having cystitis. ( 28882559 )
2017
46
A new player in interstitial cystitis/bladder pain syndrome: platelet-activating factor - PAF and its connection to smoking. ( 28408637 )
2017
47
Viral-specific T-cell response in hemorrhagic cystitis after haploidentical donor stem cell transplantation. ( 28865164 )
2017
48
Successful Treatment of BK Virus Hemorrhagic Cystitis (HC) Post Allogenic Hematopoietic Stem Cell Transplantation with Low Dose Cidofovir. ( 28598058 )
2017
49
Xanthogranulomatous cystitis in a child. ( 28894338 )
2017
50
Interventions to treat hemorrhagic cystitis: a systematic review and meta-analysis. ( 28462435 )
2017

Variations for Cystitis

Expression for Cystitis

Search GEO for disease gene expression data for Cystitis.

Pathways for Cystitis

Pathways related to Cystitis according to GeneCards Suite gene sharing:

(show all 35)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.89 EGF FZD8 IL6 NGF PTGS2 TLR4
2
Show member pathways
12.75 CXCL8 IL6 TACR1 TLR4 TNF
3
Show member pathways
12.65 EGF IL6 NGF TLR4 TNF
4
Show member pathways
12.51 CXCL8 IL6 PTGS2 TLR4 TNF
5
Show member pathways
12.29 CRP IL6 PTGS2 TNF
6
Show member pathways
12.28 CXCL8 IL6 PTGS2 TNF
7 12.25 FZD8 HBEGF TLR4 TNF
8
Show member pathways
12.21 CXCL8 IL6 TLR4 TNF
9
Show member pathways
12.17 CXCL8 IL6 PTGS2 TLR4 TNF
10
Show member pathways
12.12 CXCL8 IL6 TLR4 TNF
11
Show member pathways
12.05 EGF FZD8 HBEGF IL6
12 11.95 EGF FZD8 IL6 PTGS2 TLR4 TNF
13 11.93 CXCL8 IL6 PTGS2 TNF
14 11.85 CXCL8 IL6 NGF TAC1 TACR1 TNF
15 11.84 CXCL8 IL6 TLR4 TNF
16 11.83 CXCL8 PTGS2 TLR4 TNF
17 11.79 CXCL8 IL6 TLR4 TNF
18 11.78 CXCL8 IL6 TLR4
19
Show member pathways
11.72 CXCL8 PTGS2 TNF
20 11.69 CXCL8 IL6 TLR4 TNF
21 11.66 CXCL8 EGF HBEGF UPK3A
22 11.64 IL6 TLR4 TNF
23 11.63 CXCL8 HBEGF IL6
24 11.56 CXCL8 EGF IL6 TNF
25
Show member pathways
11.53 CXCL8 IL6 PTGS2 TNF
26 11.51 CXCL8 IL6 PTGS2 TACR1 TLR4 TNF
27 11.5 CXCL8 IL6 PTGS2
28 11.49 HBEGF IL6 TNF
29 11.46 IL6 KNG1 TNF
30 11.45 CXCL8 IL6 TLR4 TNF
31 11.36 CXCL8 IL6 PTGS2 TNF
32 11.31 CXCL8 IL6 TLR4 TNF
33 11.3 IL6 TLR4 TNF
34 10.47 TAC1 TACR1
35 10.3 CRP CXCL8 IL6 PTGS2 TNF

GO Terms for Cystitis

Cellular components related to Cystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.77 CKAP4 EGF FZD8 HBEGF KNG1 P2RX3
2 extracellular space GO:0005615 9.76 CRP CXCL8 EGF HBEGF IL6 KNG1
3 extracellular region GO:0005576 9.32 CRP CXCL8 EGF HBEGF IL6 KNG1

Biological processes related to Cystitis according to GeneCards Suite gene sharing:

(show all 37)
# Name GO ID Score Top Affiliating Genes
1 angiogenesis GO:0001525 9.95 CXCL8 EGF FZD8 PTGS2
2 positive regulation of gene expression GO:0010628 9.93 CRP EGF IL6 NGF TLR4 TNF
3 positive regulation of apoptotic process GO:0043065 9.91 IL6 KNG1 NGF PTGS2 TNF TRPV1
4 positive regulation of cytosolic calcium ion concentration GO:0007204 9.87 KNG1 TAC1 TACR1 TRPV1
5 cellular response to lipopolysaccharide GO:0071222 9.86 CXCL8 IL6 TLR4 TNF
6 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.84 EGF HBEGF IL6
7 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.83 IL6 PTGS2 TNF
8 regulation of inflammatory response GO:0050727 9.82 PTGS2 TLR4 TNF
9 regulation of blood pressure GO:0008217 9.81 PTGS2 TAC1 TACR1
10 response to glucocorticoid GO:0051384 9.8 IL6 PTGS2 TNF
11 positive regulation of interleukin-6 production GO:0032755 9.78 IL6 TLR4 TNF
12 response to heat GO:0009408 9.77 P2RX3 TACR1 TRPV1
13 positive regulation of smooth muscle cell proliferation GO:0048661 9.71 HBEGF IL6 PTGS2 TNF
14 positive regulation of NF-kappaB import into nucleus GO:0042346 9.69 PTGS2 TLR4 TNF
15 positive regulation of renal sodium excretion GO:0035815 9.67 TAC1 TACR1
16 positive regulation of synaptic transmission, GABAergic GO:0032230 9.67 TAC1 TACR1
17 response to pain GO:0048265 9.67 TAC1 TACR1 TRPV1
18 sensory perception of pain GO:0019233 9.67 PTGS2 TAC1 TACR1 TRPV1
19 positive regulation of acute inflammatory response GO:0002675 9.66 IL6 TAC1
20 cellular response to ATP GO:0071318 9.66 PTGS2 TRPV1
21 negative regulation of blood vessel diameter GO:0097756 9.65 CRP PTGS2
22 positive regulation of chemokine production GO:0032722 9.65 IL6 TLR4 TNF
23 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.62 TLR4 TNF
24 tachykinin receptor signaling pathway GO:0007217 9.62 TAC1 TACR1
25 positive regulation of action potential GO:0045760 9.61 TAC1 TACR1
26 urinary bladder smooth muscle contraction GO:0014832 9.59 P2RX3 TRPV1
27 positive regulation of fever generation GO:0031622 9.58 PTGS2 TNF
28 detection of abiotic stimulus GO:0009582 9.58 TAC1 TACR1
29 positive regulation of saliva secretion GO:0046878 9.55 TAC1 TACR1
30 positive regulation of synaptic transmission, cholinergic GO:0032224 9.54 TAC1 TACR1
31 smooth muscle contraction involved in micturition GO:0060083 9.52 TACR1 TRPV1
32 behavioral response to pain GO:0048266 9.5 P2RX3 TACR1 TRPV1
33 positive regulation of nitric oxide biosynthetic process GO:0045429 9.46 PTGS2 TLR4 TNF TRPV1
34 negative regulation of lipid storage GO:0010888 9.43 CRP IL6 TNF
35 inflammatory response GO:0006954 9.32 CRP CXCL8 IL6 KNG1 PTGS2 TAC1
36 positive regulation of lymphocyte proliferation GO:0050671 9.13 TAC1 TACR1 TLR4
37 regulation of receptor activity GO:0010469 10.04 CXCL8 HBEGF IL6 NGF TNF

Molecular functions related to Cystitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 9.35 FZD8 KNG1 NGF TAC1 TLR4
2 growth factor activity GO:0008083 8.92 EGF HBEGF IL6 NGF

Sources for Cystitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....